3 recruiting, 3 unknown, 1 completed. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Recruiting 3, Unknown 3, Completed 1 |
| Phase 2 | 2 | Unknown 2 |
Follow TIA: new trials by email Literature Review of TIA trials Research Report on TIA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4） Tirofiban, Placebo - Ischemic Stroke, Acute, TIA | Phase 3 | Recruiting | Beijing Tiantan Hospital | 4674 | 2024-07-11 | 2024-07-12 |
| Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis Probucol, Placebo probucol - Ischemic Stroke, TIA | Phase 3 | Recruiting | First Affiliated Hospital of Wannan Medical College | 5452 | 2024-06-15 | 2026-10-30 |
| Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg - Stroke, Stroke, Ischemic | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 2800 | 2023-05-17 | 2025-09-08 |
| Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3) Colchicine, Placebo colchicine - Ischemic Stroke, TIA | Phase 3 | Completed | Beijing Tiantan Hospital | 8343 | 2022-08-11 | 2024-06-25 |
| PeRiodontal Treatment to Eliminate Minority InEquality and Rural Disparities in Stroke Intensive dental treatment, Standard dental treatment, Arestin - Periodontal Disease, Stroke | Phase 3 | Unknown | University of South Carolina | 400 | 2015-12-01 | 2019-04-18 |
| Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events Apixaban, Clopidogrel, Aspirin - Ischemic Stroke, TIA | Phase 2 / Phase 3 | Unknown | Xijing Hospital | 10000 | 2014-01-01 | 2013-08-16 |
| Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events rivaroxaban, Aspirin, placebo - Ischemic Stroke, TIA | Phase 2 / Phase 3 | Unknown | Xijing Hospital | 3700 | 2013-09-01 | 2013-08-16 |
Ischemic Stroke (6) · Stroke (3) · Angina, Unstable (1) · Atherosclerosis (1) · Cerebral Infarction (1) · Heart Diseases (1) · Myocardial Infarction (1) · Periodontal Diseases (1)
Brain Diseases (7) · Cardiovascular Diseases (7) · Central Nervous System Diseases (7) · Cerebrovascular Disorders (7) · Nervous System Diseases (7) · Vascular Diseases (7) · Stroke (4) · Angina Pectoris (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Brain Infarction (1) · Brain Ischemia (1) · Chest Pain (1) · Infarction (1) · Ischemia (1)
Aspirin (3) · Colchicine (2) · Aircraft (1) · Clopidogrel (1) · Minocycline (1) · Probucol (1) · Rivaroxaban (1) · Ticagrelor (1) · Tirofiban (1) · Tooth Exfoliation (1) · apixaban (1)
Beijing Tiantan Hospital (2) · Xijing Hospital (2) · Assistance Publique - Hôpitaux de Paris (1) · First Affiliated Hospital of Wannan Medical College (1) · University of South Carolina (1)
China (5) · France (1) · United States (1)
Gang Zhao, M.D. (2) · Souvik Sen, MD (1)
PMID 26458895, PMID 37060288, PMID 38925803, PMID 40273963, PMID 40496882